| Market Capitalization (Millions $) |
1,447 |
| Shares
Outstanding (Millions) |
96 |
| Employees |
123 |
| Revenues (TTM) (Millions $) |
6 |
| Net Income (TTM) (Millions $) |
-36 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Adlai Nortye Ltd. is a Cayman Islands holding company with subsidiaries in the United States and mainland China that conduct its daily operations. The company develops drug candidates, conducts preclinical studies and clinical trials, and aims to commercialize these drug candidates. It operates primarily through its subsidiaries and manages cash transfers and dividend distributions among them.
|
2.41%